Protective efficacy of antigenic fractions in mouse models of cryptococcosis.
D000818:Animals; D000946:Antigens, Fungal / Q000008:administration & dosage* / Q000302:isolation & purification; D001402:B-Lymphocytes / Q000276:immunology; D003453:Cryptococcosis / Q000276:immunology* / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D003455:Cryptococcus neoformans / Q000276:immunology* / Q000302:isolation & purification / Q000472:pathogenicity; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D005657:Fungal Vaccines / Q000008:administration & dosage; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D009928:Organ Specificity; D011134:Polysaccharides / Q000008:administration & dosage / Q000276:immunology / Q000302:isolation & purification; D013601:T-Lymphocytes / Q000276:immunology
D000946:Antigens, Fungal; D016207:Cytokines; D005657:Fungal Vaccines; D011134:Polysaccharides